Pierre Scotney

VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis

Fan Zhang, Zhongshu Tang, Xu Hou et al. · Proceedings of the National Academy of Sciences · 2009 · 308 citations · Full text

Medicine, Molecular Medicine, Pharmacology +14

Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes

Carolina E. Hagberg, Annika Mehlem, Annelie Falkevall et al. · Nature · 2012 · 291 citations

Medicine, Endocrinology, Pharmacology +16

VEGF-B inhibits apoptosis via VEGFR-1–mediated suppression of the expression of BH3-only protein genes in mice and rats

Yang Li, Fan Zhang, Nobuo Nagai et al. · Journal of Clinical Investigation · 2008 · 194 citations · Full text

Life Sciences, Cell Biology, Pharmacology +17

Reducing VEGF-B Signaling Ameliorates Renal Lipotoxicity and Protects against Diabetic Kidney Disease

Annelie Falkevall, Annika Mehlem, Isolde Palombo et al. · Cell Metabolism · 2017 · 176 citations · Full text

Medicine, Biochemistry, Nephrology +14

Endogenous IL-11 Signaling Is Essential in Th2- and IL-13–Induced Inflammation and Mucus Production

Chun Geun Lee, Dominik Hartl, Hiroshi Matsuura et al. · American Journal of Respiratory Cell and Molecular Biology · 2008 · 75 citations · Full text

Life Sciences, Immunology, Pathobiology +17